Trials that use: P-values
New to this method? Read the tutorial →
10,201 results
- BudERIndependent statistical analysis of Effect of Nebulized Budesonide and Oral Corticosteroids on Wheezing Episode Relapse in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Buffered vs. Unbuffered Local Anesthesia in Mandibular Molars Diagnosed With Symptomatic Irreversible Pulpitis: Complete Statistical AnalysisIndependent statistical analysis of Buffered vs. Unbuffered Local Anesthesia in Mandibular Molars Diagnosed With Symptomatic Irreversible Pulpitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- buffering SLNIndependent statistical analysis of Does Alkalinization Reduce Perceived Pain Levels During Sentinel Lymph Node Imaging?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Building and Pilot Testing a Couples-based Smartphone Systems to Address Alcohol Use Disorder: Complete Statistical AnalysisIndependent statistical analysis of Building and Pilot Testing a Couples-based Smartphone Systems to Address Alcohol Use Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- BULLDOGIndependent statistical analysis of Comparison of Tear Evaporation Rate With Systane Complete in Dry Eye and Non-Dry Eye: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- BULLETIndependent statistical analysis of BULLET: Bladder Ultrasound Limits Length (of Time), Expedites Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03860311).
- Bundling and Unbundling the Laparoscopic Electrosurgery Cord With the Camera Cord: Complete Statistical AnalysisIndependent statistical analysis of Bundling and Unbundling the Laparoscopic Electrosurgery Cord With the Camera Cord: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Buoy Electrolyte Study on Hydration Status of Active Men and Women: Complete Statistical AnalysisIndependent statistical analysis of Buoy Electrolyte Study on Hydration Status of Active Men and Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis: Complete Statistical AnalysisIndependent statistical analysis of Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Buprenorphine 8 mg Sublingual Tablets Under Fasting Conditions: Complete Statistical AnalysisIndependent statistical analysis of Buprenorphine 8 mg Sublingual Tablets Under Fasting Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01157169).
- Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients: Complete Statistical AnalysisIndependent statistical analysis of Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00879996).
- Buprenorphine Extended-Release Subcutaneous Injection (RBP-6000) in High-risk Users: Complete Statistical AnalysisIndependent statistical analysis of Buprenorphine Extended-Release Subcutaneous Injection (RBP-6000) in High-risk Users: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04995029).
- Buprenorphine Plus Baclofen to Increase Analgesia in Healthy Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Buprenorphine Plus Baclofen to Increase Analgesia in Healthy Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04251819).
- Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Buspirone for Functional Dysphagia: Complete Statistical AnalysisIndependent statistical analysis of Buspirone for Functional Dysphagia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02674412).
- Buspirone Therapy for Localized Epilepsy: Complete Statistical AnalysisIndependent statistical analysis of Buspirone Therapy for Localized Epilepsy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01496612).
- Busulfan and Cyclophosphamide Followed By ALLO BMT: Complete Statistical AnalysisIndependent statistical analysis of Busulfan and Cyclophosphamide Followed By ALLO BMT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01685411).
- Busulfan and Fludarabine Followed by Post-transplant Cyclophosphamide: Complete Statistical AnalysisIndependent statistical analysis of Busulfan and Fludarabine Followed by Post-transplant Cyclophosphamide: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00800839).
- Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT): Complete Statistical AnalysisIndependent statistical analysis of Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00361140).
- Busulfan-fludarabine Conditioning and T-cell Depleted Allogeneic Stem Cell Transplantation for Patients With Advanced Hematologic Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Busulfan-fludarabine Conditioning and T-cell Depleted Allogeneic Stem Cell Transplantation for Patients With Advanced Hematologic Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- BUTTERFLEYEIndependent statistical analysis of Study to Assess the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Compared to Laser Photocoagulation in Patients With Retinopathy of Prematurity: primary endpoint results, effect estimate with confidence…
- Buttonhole Versus Step Ladder Cannulation in High Dose Hemodialysis: Complete Statistical AnalysisIndependent statistical analysis of Buttonhole Versus Step Ladder Cannulation in High Dose Hemodialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01962025).
- Buzzy Versus Vapocoolant Spray: Pediatric Needle Pain Relief: Complete Statistical AnalysisIndependent statistical analysis of Buzzy Versus Vapocoolant Spray: Pediatric Needle Pain Relief: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00919100).
- BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03264131).
- BVU-R15Independent statistical analysis of Knowledge Accessibility and Availability in Forming Knowledge-to-Text Inferences Among Middle Grade Readers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- BWP-ADIndependent statistical analysis of Enhancing Consent for Alzheimer's Research: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00453544).
- BWSP3Independent statistical analysis of Black Widow Spider Antivenin for Patients With Systemic Latrodectism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00657540).
- C_ASCENTIndependent statistical analysis of Evaluating the Safety and Effectiveness of Interferon-Free Treatment of Hepatitis C Virus Infection in HIV-Coinfected Adults on Antiretroviral Therapy: primary endpoint results, effect estimate with confidence interval, sample-size…
- C-CADIndependent statistical analysis of Community-Based Communication Approaches for Blood Donation in Ghana: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04783077).
- C-earlyIndependent statistical analysis of A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve…
- C-OPTIMISEIndependent statistical analysis of Study to Evaluate Maintenance of Sustained Remission of axSpA With CZP Compared to Placebo: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- C-Pulse IDE Feasibility Study- A Heart Assist System: Complete Statistical AnalysisIndependent statistical analysis of C-Pulse IDE Feasibility Study- A Heart Assist System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00815880).
- C-RESULTSIndependent statistical analysis of Correcting Residual Errors With Spectral, Ultrasound, Traditional Speech Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03737318).
- C-ScanIndependent statistical analysis of Safety,Usability and Compliance of Using C-Scan System for Providing Information on Colonic Polypoid Lesions and Masses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- C. Difficile and Ursodiol: Complete Statistical AnalysisIndependent statistical analysis of C. Difficile and Ursodiol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02748616).
- C/SOAPIndependent statistical analysis of Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks: Complete Statistical AnalysisIndependent statistical analysis of C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- C1 Esterase Inhibitor in Hereditary Angioedema (HAE)(Extension Study): Complete Statistical AnalysisIndependent statistical analysis of C1 Esterase Inhibitor in Hereditary Angioedema (HAE)(Extension Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00292981).
- C3Independent statistical analysis of Community Network-driven COVID-19 Testing and Vaccination of Vulnerable Populations in the Central US: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- C3POIndependent statistical analysis of Cerebral Perfusion Pressure Using Precedex and Other Sedatives: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01169467).
- C7-T1 Epidural Steroid Injections Versus Targeted Injection for Treatment of Cervical Radicular Pain: Complete Statistical AnalysisIndependent statistical analysis of C7-T1 Epidural Steroid Injections Versus Targeted Injection for Treatment of Cervical Radicular Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- CAIndependent statistical analysis of Effectiveness Study of Different Local Anesthetic Mixtures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01243112).
- Cabergoline in Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Cabergoline in Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01730729).
- Cabozantinib and Androgen Ablation in Patients With Androgen-Dependent Metastatic Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Cabozantinib and Androgen Ablation in Patients With Androgen-Dependent Metastatic Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma: Complete Statistical AnalysisIndependent statistical analysis of Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Cabozantinib for Adults With Advanced Soft Tissue Sarcoma: Complete Statistical AnalysisIndependent statistical analysis of Cabozantinib for Adults With Advanced Soft Tissue Sarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01755195).
- Cabozantinib in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC): Complete Statistical AnalysisIndependent statistical analysis of Cabozantinib in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04631744).
- Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer: Complete Statistical AnalysisIndependent statistical analysis of Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Cabozantinib-S-Malate and Erlotinib Hydrochloride in Treating Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Cabozantinib-S-Malate and Erlotinib Hydrochloride in Treating Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…